Pinostilbene (0- 40 μM; 24 hours, 48 hours) does not cause significant inhibition on the growth of normal colon cells.
Pinostilbene (20 μM, 40 μM; 24 hours, 48 hours) causes a significant and dose-dependent increase in the percentage of cells in S phase in both HCT116 and HT29 cells compared to the control cells.
Pinostilbene at μM also induces a modest increase of cell population in G2/M phase in HT29 cells.
Pinostilbene(20 μM, 40 μM; 24 hours, 48 hours) modulates expression of key signaling proteins related to cell proliferation and apoptosis.
Pinostilbene also acts as a resveratrol methylated derivative and displays protective effects against 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells.
Cell Viability Assay
|
Cell Line:
|
HCT116 cells, HT29 cells
|
|
Concentration:
|
24 hours, 48 hours
|
|
Incubation Time:
|
0-100 μM
|
|
Result:
|
Inhibited the growth of two human colon cancer cells.
|
Apoptosis Analysis
|
Cell Line:
|
HCT116 cells, HT29 cells
|
|
Concentration:
|
20 μM, 40 μM
|
|
Incubation Time:
|
24 hours, 48 hours
|
|
Result:
|
Caused a significant and dose-dependent increase in the percentage of cells in S phase.
|
Cell Viability Assay
|
Cell Line:
|
HCT116 cells
|
|
Concentration:
|
20 μM,40 μM
|
|
Incubation Time:
|
24 hours, 48 hours
|
|
Result:
|
Significantly increased the expression levels of p53, Bax, cleaved caspase-3, cleaved PARP and p21
Cip1/Waf1
, while decreased the expression levels of cyclin E and p-Rb.
|